Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Molecular Genetics

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDM315PMID 17984172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pathogenesis of spinocerebellar ataxia

  2008cited by this paper
• 14-3-3 Protein Interacts with Huntingtin-associated Protein 1 and Regulates Its Trafficking*

  2007cited by this paper
• Trinucleotide repeat disorders.

  2007cited by this paper
• Regulation of intracellular HAP1 trafficking

  2007cited by this paper
• Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle.

  2006cited by this paper
• The Drosophila phosphatidylinositol transfer protein encoded by vibrator is essential to maintain cleavage-furrow ingression in cytokinesis

  2006cited by this paper
• Does isoform diversity explain functional differences in the 14-3-3 protein family?

  2006cited by this paper
• Hypothesis: Huntingtin may function in membrane association and vesicular trafficking.

  2006cited by this paper
• CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and Degradation*

  2006cited by this paper
• GAPs in growth factor signalling

  2005cited by this paper
• Normal huntingtin function: an alternative approach to Huntington's disease

  2005cited by this paper
• Huntingtin Associates with Acidic Phospholipids at the Plasma Membrane*

  2005cited by this paper
• Phosphorylation of Arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced Toxicity by Rescuing Proteasome Impairment*

  2005cited by this paper
• The Role of RNA and RNA Processing in Neurodegeneration

  2005cited by this paper
• Synaptic dysfunction in Huntington’s disease: a new perspective

  2005cited by this paper
• Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles

  2005influential reference
• Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases.

  2004cited by this paper
• The serum‐ and glucocorticoid‐induced kinase SGK inhibits mutant huntingtin‐induced toxicity by phosphorylating serine 421 of huntingtin

  2004cited by this paper
• Rho GTPases regulate axon growth through convergent and divergent signaling pathways.

  2004cited by this paper
• Biological functions of phosphatidylinositol transfer proteins.

  2004cited by this paper
• Huntingtin and the molecular pathogenesis of Huntington's disease

  2004cited by this paper
• Deranged neuronal calcium signaling and Huntington disease.

  2004cited by this paper
• Pathogenic RNA repeats: an expanding role in genetic disease.

  2004cited by this paper
• Biochemical Aspects of Neurodegeneration in Human Brain: Involvement of Neural Membrane Phospholipids and Phospholipases A2

  2004cited by this paper
• Current Thoughts on the Phosphatidylinositol Transfer Protein Family

  2003cited by this paper
• A neurotoxic peripherin splice variant in a mouse model of ALS

  2003cited by this paper
• Transcriptional abnormalities in Huntington disease.

  2003cited by this paper
• Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

  2003influential reference
• Unfolding the role of protein misfolding in neurodegenerative diseases

  2003cited by this paper
• RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.

  2003cited by this paper
• The molecular bases of spinal muscular atrophy.

  2002cited by this paper
• Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

  2002cited by this paper
• The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms.

  2002cited by this paper
• The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

  2002cited by this paper
• Mouse and fly models of neurodegeneration.

  2002influential reference
• Homophila: human disease gene cognates in Drosophila

  2002cited by this paper
• Current thoughts on the phosphatidylinositol transfer protein family

  2002cited by this paper
• Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

  2001cited by this paper
• pasilla, the Drosophila homologue of the human Nova-1 and Nova-2 proteins, is required for normal secretion in the salivary gland.

  2001cited by this paper
• Beyond the Qs in the polyglutamine diseases.

  2001cited by this paper
• The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.

  2001cited by this paper
• Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches

  2000cited by this paper
• Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type‐1

  2000cited by this paper
• Identification of genes that modify ataxin-1-induced neurodegeneration

  2000influential reference
• The latest in signal transduction, 1999. Specificity in Signal Transduction, Keystone, Colorado, USA, 9-14 April 1999.

  1999cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Intranuclear Neuronal Inclusions : Minireview A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases ?

  1997cited by this paper
• Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?

  1997cited by this paper
• Spinocerebellar ataxia type 1.

  1995cited by this paper
• Spinocerebellar ataxia type 1.

  1995cited by this paper
• Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

  1993cited by this paper

• eVGeMdb: a manually curated database for experimentally validated genetic modifiers of neurodegenerative disorders

  2026cites this paper
• Comparative Analysis of Two Autophagy-Enhancing Small Molecules (AUTEN-67 and -99) in a Drosophila Model of Spinocerebellar Ataxia Type 1

  2025cites this paper
• Dendrite injury triggers neuroprotection in Drosophila models of neurodegenerative disease

  2024influential citation
• A multi‐layered network model identifies Akt1 as a common modulator of neurodegeneration

  2023cites this paper
• An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells

  2022cites this paper
• MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration.

  2022cites this paper
• Hsp40 overexpression in pacemaker neurons delays circadian dysfunction in a Drosophila model of Huntington's disease

  2022cites this paper
• Caspar, an adapter for VAPB and TER94, modulates the progression of ALS8 by regulating IMD/NFκB-mediated glial inflammation in a Drosophila model of human disease

  2022cites this paper
• Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis

  2021cites this paper
• Caspar, an adapter for VAP and TER94 delays progression of disease by regulating glial inflammation in a Drosophila model of ALS8

  2021cites this paper
• Natural genetic variation in Drosophila melanogaster reveals genes associated with Coxiella burnetii infection

  2020cites this paper
• Investigating Developmental and Epileptic Encephalopathy Using Drosophila melanogaster

  2020cites this paper
• Functional assessment of the “two-hit” model for neurodevelopmental defects in Drosophila and X. laevis

  2020cites this paper
• Transposable element activation promotes neurodegeneration in a Drosophila model of Huntington's disease

  2020cites this paper
• Understanding Neurodegeneration and Neuroprotection Through Genetic Screens in Drosophila

  2019cites this paper
• Nonmammalian Models of Huntington's Disease.

  2018cites this paper
• High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration.

  2018cites this paper
• Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias

  2018cites this paper
• High-throughput functional analysis distinguishes pathogenic, nonpathogenic, and compensatory transcriptional changes in a neurodegenerative disorder

  2018influential citation
• Gene Therapies for Polyglutamine Diseases.

  2018cites this paper
• The ataxin-1 interactome reveals direct connection with multiple disrupted nuclear transport pathways

  2018cites this paper
• Drosophila small ovary encodes a zinc-finger repressor required for ovarian differentiation

  2018cites this paper
• Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery

  2018cites this paper
• Huntington’s Disease Associated Genes: Molecular Basis of Disease and Possible New Targets for Treatment

  2017cites this paper
• Inhibition of PIP 4 K ameliorates the pathological effects of mutant huntingtin protein 1

  2017cites this paper
• Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch

  2017cites this paper
• Két autofágia aktiváló kismolekula, az AUTEN-67 és az AUTEN-99 hatásának vizsgálata Drosophila melanogaster Huntington-kór modellben

  2017cites this paper
• Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein

  2017cites this paper
• Chapter 33 – Modeling Huntington Disease in Yeast and Invertebrates

  2015cites this paper
• Lazarillo-related Lipocalins confer long-term protection against type I Spinocerebellar Ataxia degeneration contributing to optimize selective autophagy

  2015cites this paper
• Importance of gene dosage in controlling dendritic arbor formation during development

  2015cites this paper
• Studying polyglutamine diseases in Drosophila.

  2015cites this paper
• Categorizer: a tool to categorize genes into user-defined biological groups based on semantic similarity

  2014cites this paper
• Drugging unconventional targets: insights from Huntington's disease.

  2014cites this paper
• Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation.

  2014influential citation
• Gene expression profile in fibroblasts of Huntington's disease patients and controls.

  2014cites this paper
• A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.

  2014cites this paper
• alleviates cell models Huntington's disease.

  2014cites this paper
• Morphometric analysis of Huntington's disease neurodegeneration in Drosophila.

  2013cites this paper
• NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases

  2013influential citation
• Experimental Models for Identifying Modifiers of Polyglutamine-Induced Aggregation and Neurodegeneration

  2013cites this paper
• Effete, an E2 ubiquitin-conjugating enzyme with multiple roles in Drosophila development and chromatin organization

  2013cites this paper
• Unraveling the Basis of Neurodegeneration using the Drosophila Eye

  2013cites this paper
• Huntingtin’s Function in Axonal Transport Is Conserved in Drosophila melanogaster

  2013cites this paper
• Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis

  2012cites this paper
• Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms

  2012cites this paper
• FOX-2 Dependent Splicing of Ataxin-2 Transcript Is Affected by Ataxin-1 Overexpression

  2012cites this paper
• Drosophila Models of Proteinopathies: the Little Fly that Could

  2012cites this paper
• Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders

  2012cites this paper
• Mécanismes moléculaires et de signalisation induits par le stress oxydatif dans des modèles in vivo de la maladie de Parkinson chez la drosophile : intoxication au paraquat et expression de l'α-synucléine

  2012cites this paper
• Genetic Modifiers of Neurological Disease

  2012cites this paper
• Signalling Pathways in Development and Human Disease: A Drosophila Wing Perspective

  2011cites this paper
• Genetic modifiers of neurological disease.

  2011cites this paper
• H05 Gene expression profile in fibroblasts of Huntington's disease patients and controls

  2010cites this paper
• Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.

  2010cites this paper
• Exploring prion protein biology in flies

  2010cites this paper
• Kismet/CHD7 regulates axon morphology, memory and locomotion in a Drosophila model of CHARGE syndrome.

  2010cites this paper
• Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.

  2010cites this paper
• Investigation of RNA-mediated pathogenic pathways in a Drosophila model of expanded repeat disease.

  2010cites this paper
• Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation

  2010cites this paper
• Towards the treatment of polyglutamine diseases: the modulatory role of protein context.

  2010cites this paper
• PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum

  2010influential citation
• Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models

  2010influential citation
• Toxic intermediates and protein quality control in the polyglutamine disease, SCA3

  2010influential citation
• Improved Activities of CREB Binding Protein, Heterogeneous Nuclear Ribonucleoproteins and Proteasome Following Downregulation of Noncoding hsrω Transcripts Help Suppress Poly(Q) Pathogenesis in Fly Models

  2010cites this paper
• Repeat expansion diseases: when a good RNA turns bad

  2010cites this paper
• Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms

  2009cites this paper
• Two Young Sisters with Spinocerebellar Ataxia Type 2 Showing Different Clinical Progression of Disease

  2009cites this paper
• Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3.

  2009cites this paper
• Animal Models of Polyglutamine Diseases and Therapeutic Approaches*

  2009cites this paper
• Recent advances in using Drosophila to model neurodegenerative diseases

  2009cites this paper
• In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis.

  2009influential citation
• Flies as the ointment: Drosophila modeling to enhance drug discovery

  2009cites this paper
• Drosophila melanogaster as a Model Organism of Brain Diseases

  2009cites this paper
• Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model

  2008cites this paper
• Drosophila orthologues to human disease genes: an update on progress.

  2008cites this paper
• Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's β-Amyloid Overexpression in Drosophila

  2008cites this paper
• Functional genomics approaches to neurodegenerative diseases

  2008cites this paper
• Polyglutamine neurodegeneration: protein misfolding revisited.

  2008cites this paper
• Genetic Modifiers of MeCP2 Function in Drosophila

  2008cites this paper
• AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.

  2007cites this paper